CircABHD2 Inhibits Malignant Progression of Endometrial Cancer by Regulating NAD+/NAMPT Metabolism Axis
-
Published:2024-07-01
Issue:
Volume:
Page:
-
ISSN:1073-6085
-
Container-title:Molecular Biotechnology
-
language:en
-
Short-container-title:Mol Biotechnol
Author:
Li Huixin, Xu Hanzi, Liu Mengyu, Li Yang, Yuan Shenglong, Yin Ping, Gong ZhenORCID, Zhong Shanliang
Funder
Nanjing Health Science and Technology Development Special Fund Project National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022). Cancer statistics, 2022. CA: A Cancer Journal for Clinicians, 72(1), 7–33. 2. Xia, C., Dong, X., Li, H., Cao, M., Sun, D., He, S., Yang, F., Yan, X., Zhang, S., Li, N., & Chen, W. (2022). Cancer statistics in China and United States, 2022: Profiles, trends, and determinants. Chinese Medical Journal (Engl), 135(5), 584–590. 3. Murali, R., Delair, D. F., Bean, S. M., Abu-Rustum, N. R., & Soslow, R. A. (2018). Evolving roles of histologic evaluation and molecular/genomic profiling in the management of endometrial cancer. Journal of the National Comprehensive Cancer Network, 16(2), 201–209. 4. Cancer Genome Atlas Research Network, Kandoth, C., Schultz, N., Cherniack, A. D., Akbani, R., Liu, Y., Shen, H., Gordon Robertson, A., Pashtan, I., Shen, R., Benz, C. C., Yau, C., Laird, P. W., Ding, L., Zhang, W., Mills, G. B., Kucherlapati, R., Mardis, E. R., & Levine, D. A. (2013). Integrated genomic characterization of endometrial carcinoma. Nature, 497(7447), 67–73. 5. Kasius, J. C., Pijnenborg, J. M. A., Lindemann, K., Forsse, D., van Zwol, J., Kristensen, G. B., Krakstad, C., Werner, H. M. J., & Amant, F. (2021). Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification. Cancers (Basel), 13(22), 5848.
|
|